Position in BHVN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,633,042
+$83,582 QoQ
Shares Held
445,769
-42.4% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#54
of 294 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 58%
Shared 2%
None 40%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fiera Capital Corp holds $542,965,678 across 19 Biotechnology names. BHVN ranks #16 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
843,042 | $89,885,137 | |
| 2 | ARGX |
Argenx SE
|
90,423 | $83,891,746 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
1,445,885 | $53,888,133 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
99,857 | $53,618,215 | |
| 5 | QURE |
uniQure N.V.
|
909,141 | $41,875,034 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
516,997 | $29,370,599 | |
| 7 | ASND |
Ascendis Pharma A/S
|
103,313 | $27,555,643 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
405,638 | $24,484,308 |
All Filings in BHVN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,633,042 | 445,769 | Shares | Other | 2026-08-07 | |
| 2026-03-31 | $6,549,460 | 774,168 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,180,180 | 724,551 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,425,923 | 561,354 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $8,114,802 | 575,110 | Shares | Other | 2025-08-08 | |
| 2025-03-31 | $13,983,466 | 581,675 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||